Multidimensional Safety and the Cost of Compliance in Focus at the ABS UK National Committee

Committee Explores Strategies and Insights for Rapidly Evolving Maritime Industry    (LONDON) The future of safety and the cost of

READ MORE

Everything You Need to Do In The Garden In September

  September is a transitional month in the garden. This month marks the end of summer and the beginning of

READ MORE

HUMBLE’S SHARES HAVE BEEN APPROVED FOR ADMISSION TO TRADING ON NASDAQ STOCKHOLM

Nasdaq Stockholm’s listing committee has, subject to customary conditions, approved Humble Group AB’s (“Humble” or the “Company”) application for admission to

READ MORE

Lea bank ASA (LEA): Mandatory notification of trade – primary insider

Andreas Andersson, Chief Commercial Officer in Lea bank ASA, has purchased 25 000 shares in Lea bank ASA 13th September 2024

READ MORE

Amendments to the terms and conditions of Solteq Plc notes approved in written procedure

Stock exchange bulletin Other information disclosed according to the Rules of the Exchange 13 September 2024 at 3.10 p.m. EEST

READ MORE

Lagercrantz acquires Mastsystem – Lagercrantz Group

Lagercrantz has today signed an agreement to acquire 100% of the shares of Mastsystem Int’l Oy, a leading provider of high-performance

READ MORE

Prisma Properties Expands with KFC – Signs Long-Term Lease in Häggvik, Stockholm

Prisma Properties (publ) has signed a 10-year lease agreement with Nordic Service Partners, the operator of KFC in Sweden. The

READ MORE

Medius Wins 2024 ISV Partner of the Year Award in Sweden

Medius Recognized for Global Success, Innovative Use of Azure OpenAI, and Transformative Finance Solutions Medius, a leading provider of Accounts Payable

READ MORE

Boomerang Partners Celebrates 3 Years with Fivefold Increase in Sports Betting Segment

Boomerang Partners is celebrating its third anniversary of growth and achievements. Over the past three years, the company has launched more

READ MORE

BioStock: BioInvent makes a strong entrance at ESMO in Barcelona

Fri, Sep 13, 2024 11:19 CET Report this content BioInvent has released additional positive preliminary efficacy data from

READ MORE